Back
Sage Therapeutics Stock Predictions
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
22
SAGE
Sage Therapeutics
Last Price:
5.03
Seasonality Move:
10.16%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Sage Therapeutics Stock Forecast
-
Is Sage Therapeutics Stock Undervalued?
The current Sage Therapeutics [SAGE] share price is $4.91. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal. - SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
Data Unavailable
Sage Therapeutics Stock Rating
Data Unavailable
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
28.26
52-Week Low:
4.74
Prediction Charts
Market Cap:
300.36M
Price in USD:
4.91
Volume:
1.58M
Beta:
1.36
Technical Analysis
SMA50:
6.81
SMA100:
8.22
SMA200:
12.15
52-Wk Change:
-75.1%
Stock Predictions
-
Is Sage Therapeutics stock public?
Yes, Sage Therapeutics is a publicly traded company. -
What is the Sage Therapeutics stock quote today?
The Sage Therapeutics stock price is 4.91 USD today. -
How to buy Sage Therapeutics stock online?
You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 6.09 | 6.05 | 6.16 | 5.84 |
| Nov-4 | 5.92 | 5.81 | 6.12 | 5.80 |
| Nov-5 | 5.67 | 5.94 | 5.95 | 5.64 |
| Nov-6 | 6.27 | 5.95 | 6.44 | 5.93 |
| Nov-7 | 5.96 | 6.32 | 6.42 | 5.86 |
| Nov-8 | 6.33 | 6.31 | 6.39 | 6.17 |
| Nov-11 | 6.46 | 6.31 | 6.65 | 6.29 |
| Nov-12 | 6.23 | 5.73 | 6.28 | 5.73 |
| Nov-13 | 5.71 | 5.74 | 5.86 | 5.63 |
| Nov-14 | 5.87 | 5.37 | 5.87 | 5.34 |
| Nov-15 | 5.44 | 5.10 | 5.44 | 5.03 |
| Nov-18 | 5.06 | 4.78 | 5.09 | 4.74 |
| Nov-19 | 4.74 | 4.91 | 4.95 | 4.70 |
| Nov-20 | 4.75 | 4.91 | 5.13 | 4.62 |
Sage Therapeutics Earnings
Data Unavailable
Sage Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.10 per share, and an increase next year of $2.36 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.